CORVUS PHARMACEUTICALS INC CRVS
COM · Common Stock · CUSIP 221015100 · ISIN US2210151005
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersSouth San Francisco, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 29.4m as of 2019-10-29, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $5.44. Options: 2 managers hold calls ($16.0k notional), 1 hold puts ($0).
Biggest calls
| SIMPLEX TRADING, LLC | — | $16.0k30 shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | — | $00 shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | — | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
ORBIMED ADVISORS LLC
13D · may seek influence
-1.9 pts · filed 2026-01-27
Stated purposeThe Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer's Shares in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as the Reporting Persons may deem appropriate in light of the circumstances existing from time to time. If the Reporting Persons believe that further investment in the Issuer is attractive, whether because of the market price of Shares or otherwise, they may acquire Shares or other securities of the Issuer eith… Full filing |
10.3% |
| MILLER RICHARD A MD 13G · exempt (held before listing) +0.1 pts · filed 2026-02-13 | 7.8% |
| BlackRock, Inc. 13G · institution +1.1 pts · filed 2026-07-27 | 7.5% |
| Sirenia Capital Management LP 13G · institution new · filed 2026-05-15 | 7.5% |
| STATE STREET CORP 13G · institution new · filed 2026-08-07 | 5.3% |
Fell to 5% or below in the last year: Point72 Asset Management, L.P. (0.0%, 2026-05-15), VANGUARD GROUP INC (0.0%, 2026-03-26), ADAMS STREET PARTNERS LLC (3.9%, 2026-02-05)
Insider purchases and sales in Q4 2019
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2019.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| ORBIMED ADVISORS LLC 0.53% of their portfolio | 6.8m $36.8m | — |
| ADAMS STREET PARTNERS LLC 3.64% of their portfolio | 3.3m $17.8m | — |
| NOVO HOLDINGS A/S 1.03% of their portfolio | 2.9m $15.9m | — |
| BVF INC/IL 0.67% of their portfolio | 1.6m $8.9m | — |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 906.2k $4.9m | — |
| MILLENNIUM MANAGEMENT LLC 0.01% of their portfolio | 799.8k $4.4m | — |
| EcoR1 Capital, LLC 0.38% of their portfolio | 737.6k $4.0m | — |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 647.2k $3.5m | — |
| VANGUARD GROUP INC 0.00% of their portfolio | 574.2k $3.1m | — |
| DIMENSIONAL FUND ADVISORS LP 0.00% of their portfolio | 454.7k $2.5m | — |
| CHI Advisors LLC 1.52% of their portfolio | 370.3k $2.0m | — |
| BlackRock Inc. 0.00% of their portfolio | 313.8k $1.7m | — |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 275.1k $1.5m | — |
| OXFORD ASSET MANAGEMENT LLP 0.02% of their portfolio | 159.8k $869.0k | — |
| Rock Springs Capital Management LP 0.03% of their portfolio | 150.0k $816.0k | — |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 133.7k $727.0k | — |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 108.6k $591.0k | — |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 107.2k $583.0k | — |
| Connor, Clark & Lunn Investment Management Ltd. 0.00% of their portfolio | 81.8k $445.0k | — |
| Hikari Power Ltd 0.05% of their portfolio | 80.0k $435.0k | — |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 79.2k $431.0k | — |
| JACOBS LEVY EQUITY MANAGEMENT, INC 0.00% of their portfolio | 76.0k $413.0k | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 67.9k $369.0k | — |
| MORGAN STANLEY 0.00% of their portfolio | 38.6k $210.0k | — |
| Puissance Capital Management LP 0.51% of their portfolio | 38.0k $207.0k | — |
| NORTHERN TRUST CORP 0.00% of their portfolio | 26.9k $146.0k | — |
| ExodusPoint Capital Management, LP 0.00% of their portfolio | 22.9k $124.0k | — |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 22.8k $124.0k | — |
| TWO SIGMA ADVISERS, LP 0.00% of their portfolio | 16.6k $90.0k | — |
| TD Asset Management Inc 0.00% of their portfolio | 13.6k $74.0k | — |
| RAYMOND JAMES TRUST N.A. 0.00% of their portfolio | 13.2k $72.0k | — |
| MEEDER ASSET MANAGEMENT INC 0.00% of their portfolio | 2.1k $11.0k | — |
| Advisor Group, Inc. 0.00% of their portfolio | 1.0k $5.0k | — |
| Manchester Capital Management LLC 0.00% of their portfolio | 215 $1.0k | — |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 79 $430 | — |
| CITIGROUP INC 0.00% of their portfolio | 27 $0 | — |
| BARCLAYS PLC 0.00% of their portfolio | 23 $0 | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |